Quantification of BIM mRNA In Circulating Tumor Cells Of Osimertinib-treated Patients with EGFR Mutation-positive Lung Cancer

被引：0
|
作者：
Isobe, K. [1 ]
Kobayashi, H. [1 ]
Isshiki, T. [1 ]
Sakamoto, S. [1 ]
Takai, Y. [1 ]
Tomida, T. [2 ]
Adachi-Akahane, S. [2 ]
Kishi, K. [1 ]
机构：
[1] Toho Univ, Sch Med, Dept Resp Med, Tokyo, Japan
[2] Toho Univ, Sch Med, Dept Physiol, Tokyo, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P34.07
引用
收藏
页码：S417 / S418
页数：2
相关论文
共 50 条
  • [31] Osimertinib for patients with EGFR T790M mutation-positive non-small-cell lung cancer and a poor performance status
    Nakashima, Kazuhisa
    Kimura, Madoka
    Akamatsu, Hiroaki
    Daga, Haruko
    Imai, Hisao
    Taira, Tetsuhiko
    Ko, Ryo
    Hisamatsu, Yasushi
    Nishino, Kazumi
    Sugimoto, Takeya
    Miyashita, Yosuke
    Takahashi, Toshiaki
    Kumagai, Toru
    Yamamoto, Nobuyuki
    Murakami, Haruyasu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (07) : 671 - 675
  • [32] Comparison of efficacy of gefitinib and osimertinib for untreated EGFR mutation-positive non-small-cell lung cancer in patients with poor performance status
    Nakashima, Kazuhisa
    Kodama, Hiroaki
    Murakami, Haruyasu
    Takahashi, Toshiaki
    Kawakado, Keita
    Yanagawa, Takashi
    Kitani, Kashu
    Hottta, Takamasa
    Abe, Masaaki
    Hamai, Kosuke
    Tanimoto, Takuya
    Ishikawa, Nobuhisa
    Tamura, Tomoki
    Kuyama, Shoichi
    Isobe, Takeshi
    Tsubata, Yukari
    RESPIRATORY INVESTIGATION, 2024, 62 (06) : 1137 - 1141
  • [33] EGFR Gene Polymorphism Predicts Improved Outcome in Patients With EGFR Mutation-positive Non-small cell Lung Cancer Treated With Erlotinib
    Winther-Larsen, Anne
    Ebert, Eva Boysen Fynboe
    Meldgaard, Peter
    Sorensen, Boe Sandahl
    CLINICAL LUNG CANCER, 2019, 20 (03) : 161 - +
  • [34] Osimertinib for the Treatment of Metastatic EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer
    Khozin, Sean
    Weinstock, Chana
    Blumenthal, Gideon M.
    Cheng, Joyce
    He, Kun
    Zhuang, Luning
    Zhao, Hong
    Charlab, Rosane
    Fan, Ingrid
    Keegan, Patricia
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2017, 23 (09) : 2131 - 2135
  • [35] Targeting the Gatekeeper: Osimertinib in EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer
    Skoulidis, Ferdinandos
    Papadimitrakopoulou, Vassiliki A.
    CLINICAL CANCER RESEARCH, 2017, 23 (03) : 618 - 622
  • [36] Osimertinib Expanded Access Program for Previously Treated Patients With Advanced EGFR T790M Mutation-Positive NSCLC
    Santos, Edgardo
    Kaplan, Barry
    Kirshner, Eli
    Croft, Elisabeth
    Sequist, Lecia
    Burke, Lea
    Munley, Jiefen
    Oxnard, Geoffrey
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1237 - S1237
  • [37] Management of EGFR Mutation-Positive Non-Small Cell Lung Cancer
    Lilenbaum, Rogerio A.
    Horn, Leora A.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (5.5): : 672 - 674
  • [38] Role of tumor and host-derived HGF in drug resistance to EGFR inhibitors in EGFR activating mutation-positive lung cancer
    Kakiuchi, Soji
    Yano, Seiji
    Wang, Wei
    Li, Qi
    Yamada, Tadaaki
    Matsumoto, Kunio
    Hanibuchi, Masaki
    Mitsudomi, Tetsuya
    Yatabe, Yasushi
    Kuramoto, Takuya
    Otsuka, Koji
    Nishioka, Yasuhiko
    Sone, Saburo
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [39] No benefit of chemotherapy in Osimertinib-treated postoperative non-small cell lung cancer patients
    Li, Feng
    Zhao, Yi
    Zhong, Ran
    Cai, Xiuyu
    Liu, Jun
    He, Jianxing
    Liang, Wenhua
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (08) : 3689 - 3693
  • [40] Real-world osimertinib for EGFR mutation-positive non-small-cell lung cancer with acquired T790M mutation
    Imamura, Fumio
    Kimura, Madoka
    Yano, Yukihiro
    Mori, Masahide
    Suzuki, Hidekazu
    Hirashima, Tomonori
    Ihara, Shouichi
    Komuta, Kiyoshi
    Shiroyama, Takayuki
    Nagatomo, Izumi
    Kumagai, Toru
    FUTURE ONCOLOGY, 2020, 16 (21) : 1537 - 1546
12345